Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : FBIO save search
Fortress Biotech Reports 2023 Financial Results and Recent Corporate Highlights
Published: 2024-03-28 (Crawled : 20:00) - globenewswire.com
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
| Email alert
Add to watchlist
FBIO | $1.765 -2.49% -2.55% 190K
|
Health Technology
| Email alert
Add to watchlist
DERM | $3.45 -3.63% -3.77% 100K
|
| Email alert
Add to watchlist
MBIO | $0.3451 -6.98% -7.51% 130K
|
Health Technology
| Email alert
Add to watchlist
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
| Email alert
Add to watchlist
CKPT | $1.47 -8.13% -8.84% 760K
|
Health Technology
| Email alert
Add to watchlist
biotech financial results
Mustang Bio Announces Vision for CAR T-Cell Therapy Platform Expansion into Autoimmune Diseases
Published: 2024-03-28 (Crawled : 13:00) - globenewswire.com
MBIO | $0.3451 -6.98% -7.51% 130K
|
Health Technology
|
| O: 7.14%
H: 1.9%
C: -0.95%
FBIO | $1.765 -2.49% -2.55% 190K
|
Health Technology
|
| O: -0.46%
H: 0.46%
C: -7.41%
t-cell expansion vision therapy platform
Avenue Therapeutics to Host Virtual Key Opinion Leader (KOL) Event on April 4, 2024
Published: 2024-03-25 (Crawled : 13:00) - globenewswire.com
FBIO | $1.765 -2.49% -2.55% 190K
|
Health Technology
|
| O: -0.78%
H: 2.6%
C: -0.52%
ATXI | $0.1295 -3.79% -3.94% 320K
|
Health Technology
|
| O: -1.46%
H: 7.38%
C: 4.03%
key therapeutics
Checkpoint Therapeutics Reports Full-Year 2023 Financial Results and Recent Corporate Highlights
Published: 2024-03-22 (Crawled : 13:00) - globenewswire.com
FBIO | $1.765 -2.49% -2.55% 190K
|
Health Technology
|
| O: -1.02%
H: 3.08%
C: -0.77%
CKPT | $1.47 -8.13% -8.84% 760K
|
Health Technology
|
| O: -0.53%
H: 5.29%
C: 2.65%
therapeutics financial results
Journey Medical Corporation Reports Full-Year 2023 Financial Results and Recent Corporate Highlights
Published: 2024-03-21 (Crawled : 20:00) - globenewswire.com
DERM | $3.45 -3.63% -3.77% 100K
|
|
| O: -8.38%
H: 1.8%
C: -5.71%
SWKH | $17.52 1.04% 1.03% 7.7K
|
Miscellaneous
|
| O: -1.23%
H: 4.63%
C: -0.68%
FBIO | $1.765 -2.49% -2.55% 190K
|
Health Technology
|
| O: -1.02%
H: 3.08%
C: -0.77%
corporation medical financial results
Avenue Therapeutics Reports Full Year 2023 Financial Results and Recent Corporate Highlights
Published: 2024-03-18 (Crawled : 20:00) - globenewswire.com
FBIO | $1.765 -2.49% -2.55% 190K
|
Health Technology
|
| O: 2.08%
H: 0.51%
C: -3.32%
ATXI | $0.1295 -3.79% -3.94% 320K
|
Health Technology
|
| O: 3.75%
H: 2.41%
C: -3.61%
year therapeutics financial results
Journey Medical Corporation Announces U.S. FDA Acceptance of New Drug Application for DFD-29 for the Treatment of Rosacea
Published: 2024-03-18 (Crawled : 12:30) - globenewswire.com
DERM | $3.45 -3.63% -3.77% 100K
|
|
| O: 2.94%
H: 14.57%
C: 6.86%
FBIO | $1.765 -2.49% -2.55% 190K
|
Health Technology
|
| O: 3.36%
H: 0.5%
C: -4.0%
dfd-29 fda drug corporation treatment medical application
Checkpoint Therapeutics Announces Appointment of Accomplished Life Sciences Executive Amit Sharma, M.D. to Board of Directors
Published: 2024-03-18 (Crawled : 12:00) - globenewswire.com
FBIO | $1.765 -2.49% -2.55% 190K
|
Health Technology
|
| O: 3.36%
H: 0.5%
C: -4.0%
CKPT | $1.47 -8.13% -8.84% 760K
|
Health Technology
|
| O: 0.52%
H: 4.07%
C: -2.07%
life sciences therapeutics
Journey Medical Corporation to Announce Year End 2023 Financial Results on March 21, 2024
Published: 2024-03-15 (Crawled : 12:30) - globenewswire.com
DERM | $3.45 -3.63% -3.77% 100K
|
|
| O: -5.19%
H: 10.03%
C: 3.34%
FBIO | $1.765 -2.49% -2.55% 190K
|
Health Technology
|
| O: 2.98%
H: 15.03%
C: 11.85%
year corporation medical financial results
Avenue Therapeutics Receives Positive Listing Determination from Nasdaq
Published: 2024-03-15 (Crawled : 12:30) - globenewswire.com
FBIO | $1.765 -2.49% -2.55% 190K
|
Health Technology
|
| O: 2.98%
H: 15.03%
C: 11.85%
ATXI | $0.1295 -3.79% -3.94% 320K
|
Health Technology
|
| O: -0.26%
H: 13.2%
C: 1.88%
nasdaq positive therapeutics
Journey Medical Corporation to Participate in the 36th Annual ROTH Conference
Published: 2024-03-13 (Crawled : 12:30) - globenewswire.com
DERM | $3.45 -3.63% -3.77% 100K
|
|
| O: 0.0%
H: 6.9%
C: -2.01%
FBIO | $1.765 -2.49% -2.55% 190K
|
Health Technology
|
| O: -0.78%
H: 1.57%
C: -4.71%
conference corporation medical
Fortress Biotech to Participate in 36th Annual ROTH Conference
Published: 2024-03-12 (Crawled : 12:30) - globenewswire.com
FBIO | $1.765 -2.49% -2.55% 190K
|
Health Technology
|
| O: -0.5%
H: 0.5%
C: -3.27%
conference biotech
Mustang Bio Reports Full-Year 2023 Financial Results and Recent Corporate Highlights
Published: 2024-03-11 (Crawled : 20:00) - globenewswire.com
MBIO | $0.3451 -6.98% -7.51% 130K
|
Health Technology
|
| O: -1.72%
H: 3.51%
C: -7.02%
FBIO | $1.765 -2.49% -2.55% 190K
|
Health Technology
|
| O: -0.5%
H: 0.5%
C: -3.27%
financial results
Journey Medical Corporation Announces Presentation of Data from Phase 1 Clinical Trial Assessing the Impact of DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) on Microbial Flora of Healthy Adults at 2024 AAD Annual Meeting
Published: 2024-03-11 (Crawled : 12:30) - globenewswire.com
DERM | $3.45 -3.63% -3.77% 100K
|
|
| O: -1.45%
H: 0.88%
C: -0.88%
FBIO | $1.765 -2.49% -2.55% 190K
|
Health Technology
|
| O: -0.48%
H: 2.87%
C: -4.31%
dfd-29 presentation corporation meeting impact medical trial
Avenue Therapeutics to Present BAER-101 Preclinical Data at American Society for Experimental Neurotherapeutics (ASENT) 2024 Annual Meeting
Published: 2024-03-11 (Crawled : 12:00) - globenewswire.com
FBIO | $1.765 -2.49% -2.55% 190K
|
Health Technology
|
| O: -0.48%
H: 2.87%
C: -4.31%
ATXI | $0.1295 -3.79% -3.94% 320K
|
Health Technology
|
| O: -7.03%
H: 0.0%
C: -9.24%
baer-101 preclinical meeting therapeutics
Mustang Bio Announces Publication in Nature Medicine of Data from Phase 1 Trial Evaluating MB-101 IL13Rα2-targeted CAR T-Cells in High-Grade Glioma
Published: 2024-03-07 (Crawled : 12:30) - globenewswire.com
MBIO | $0.3451 -6.98% -7.51% 130K
|
Health Technology
|
| O: 8.33%
H: 4.2%
C: -2.8%
FBIO | $1.765 -2.49% -2.55% 190K
|
Health Technology
|
| O: 2.93%
H: 0.0%
C: -9.21%
mb-101 publication trial
City of Hope-developed Chimeric Antigen Receptor (CAR) T Cell Therapy Shows Clinical Activity in Patients With Aggressive Brain Tumors in a Phase 1 Trial
Published: 2024-03-07 (Crawled : 12:30) - biospace.com/
FNCTF | News | $11.0354 -20.84% 320
|
Communications
|
| O: 0.79%
H: 0.78%
C: 0.78%
MBIO | $0.3451 -6.98% -7.51% 130K
|
Health Technology
|
| O: 8.33%
H: 4.2%
C: -2.8%
FBIO | $1.765 -2.49% -2.55% 190K
|
Health Technology
|
| O: 2.93%
H: 0.0%
C: -9.21%
tumors cell city trial therapy
Fortress Biotech and Cyprium Therapeutics Announce $4.1 Million Grant from NINDS to Further Development of AAV-ATP7A Gene Therapy for Menkes Disease
Published: 2024-03-04 (Crawled : 13:30) - globenewswire.com
FBIO | $1.765 -2.49% -2.55% 190K
|
Health Technology
|
| O: 2.47%
H: 5.02%
C: -8.03%
disease biotech million grant therapeutics therapy
Avenue Therapeutics Announces Publication in Drug Development Research Highlighting First-In-Class Preclinical Data of BAER-101 in a Translational Model of Absence Epilepsy
Published: 2024-02-22 (Crawled : 13:30) - globenewswire.com
FBIO | $1.765 -2.49% -2.55% 190K
|
Health Technology
|
| O: 1.73%
H: 1.14%
C: -0.57%
ATXI | $0.1295 -3.79% -3.94% 320K
|
Health Technology
|
| O: -2.95%
H: 2.62%
C: -1.93%
baer-101 drug publication research preclinical therapeutics
Checkpoint Therapeutics Announces $14 Million Registered Direct Offering Priced At-the-Market
Published: 2024-01-29 (Crawled : 13:00) - globenewswire.com
FBIO | $1.765 -2.49% -2.55% 190K
|
Health Technology
|
| O: -2.43%
H: 6.97%
C: 4.48%
CKPT | $1.47 -8.13% -8.84% 760K
|
Health Technology
|
| O: 0.6%
H: 24.26%
C: 17.75%
million direct offering therapeutics
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.